- Business Wire•23 hours ago
Cytori Therapeutics, Inc. announced today the publication of preclinical safety and efficacy study data using Cytori Cell Therapy™ for combined radiation and thermal injury.
- Capital Cube•7 days ago
Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Cytori Therapeutics, Inc. Here are 5 ETF’s with the largest exposure to CYTX-US. Comparing the performance and risk of Cytori Therapeutics, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)
- Business Wire•29 days ago
Cytori Therapeutics, Inc. announced today that its licensee Kerastem Technologies, LLC, has completed enrollment of STYLE, a US phase II clinical trial investigating early stage female and male pattern hair loss.
Cytori Therapeutics, Inc. (CYTX)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
|Ask||4.00 x 400|
|Day's Range||1.84 - 1.89|
|52wk Range||1.78 - 6.15|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-1.74|
|Avg Vol (3m)||124,247|
|Dividend & Yield||N/A (N/A)|